Concepedia
Statistics
Publications
9
Citations
526
H-Index
Active since
2002
Affiliations
BC Cancer Agency(Current)
Cancer Research UK
University of Southampton
Ionis Pharmaceuticals (United States)
Southampton General Hospital
Jorg Michels is an author at BC Cancer Agency specializing in oncology, medicine, and chemotherapy.
Publications per year
2002–2024
Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.
Pier Luigi Zinzani, Maurizio Martelli, M Bertini et al. · PubMed · 2002 · 182 citations
Medicine, Oncology, Chemotherapy +13
Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage
Jorg Michels, Jason O’Neill, Claire Dallman et al. · Oncogene · 2004 · 136 citations
Life Sciences, Cell Biology, Oncology +15
First‐ and second‐line chemotherapy with docetaxel or mitoxantrone in patients with hormone‐refractory prostate cancer
Jorg Michels, Trina Montemurro, Nevin Murray et al. · Cancer · 2006 · 70 citations · Full text
Medicine, Oncology, Pharmacotherapy +15
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 49 citations · Full text
Medicine, Oncology, Surgery +15
Immunohistochemical analysis of the antiapoptotic Mcl‐1 and Bcl‐2 proteins in follicular lymphoma
Jorg Michels, Vipul Foria, Ben Mead et al. · British Journal of Haematology · 2006 · 21 citations · Full text
Medicine, Hematology, Oncology +17
1–5 of 9